Home
/
BIOGEN INC.
/
Financials
/
Quarterly
BIOGEN INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOGEN INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.53B
Oct 30, 2025
Q2
2025
Jun 30, 2025
$2.65B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$2.43B
May 1, 2025
Q3
2025
Sep 30, 2024
$2.47B
Oct 30, 2025
Q2
2025
Jun 30, 2024
$2.46B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$2.29B
May 1, 2025
Q3
2024
Sep 30, 2023
$2.53B
Oct 30, 2024
Q2
2024
Jun 30, 2023
$2.46B
Aug 1, 2024
Q1
2024
Mar 31, 2023
$2.46B
Apr 24, 2024
Q3
2023
Sep 30, 2022
$2.51B
Nov 8, 2023
Q1
2022
Jun 30, 2022
$2.59B
Jul 20, 2022
Q2
2023
Jun 30, 2022
$2.59B
Jul 25, 2023
Q1
2023
Mar 31, 2022
$2.53B
Apr 25, 2023
Q3
2022
Sep 30, 2021
$2.78B
Oct 25, 2022
Q1
2022
Jun 30, 2021
$2.78B
Jul 20, 2022
Q2
2021
Jun 30, 2021
$2.78B
Jul 22, 2021
Q1
2022
Mar 31, 2021
$2.69B
May 3, 2022
Q3
2021
Sep 30, 2020
$3.38B
Oct 20, 2021
Q2
2021
Jun 30, 2020
$3.68B
Jul 22, 2021
Q1
2021
Mar 31, 2020
$3.53B
Apr 22, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$466.50M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$634.80M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$240.50M
May 1, 2025
Q3
2025
Sep 30, 2024
$388.50M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$583.60M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$393.40M
May 1, 2025
Q3
2024
Sep 30, 2023
($68.10M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
$591.60M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$387.90M
Apr 24, 2024
Q3
2023
Sep 30, 2022
$1.13B
Nov 8, 2023
Q2
2023
Jun 30, 2022
$1.06B
Jul 25, 2023
Q1
2022
Jun 30, 2022
$1.06B
Jul 20, 2022
Q1
2023
Mar 31, 2022
$303.80M
Apr 25, 2023
Q3
2022
Sep 30, 2021
$329.20M
Oct 25, 2022
Q1
2022
Jun 30, 2021
$448.50M
Jul 20, 2022
Q2
2021
Jun 30, 2021
$448.50M
Jul 22, 2021
Q1
2022
Mar 31, 2021
$410.20M
May 3, 2022
Q3
2021
Sep 30, 2020
$701.50M
Oct 20, 2021
Q2
2021
Jun 30, 2020
$1.54B
Jul 22, 2021
Q1
2021
Mar 31, 2020
$1.40B
Apr 22, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2022
Mar 31, 2022
$610.70M
May 3, 2022
Q3
2021
Sep 30, 2021
$794.00M
Oct 20, 2021
Q2
2021
Jun 30, 2021
$485.70M
Jul 22, 2021
Q1
2022
Mar 31, 2021
$973.90M
May 3, 2022
Q3
2021
Sep 30, 2020
$1.09B
Oct 20, 2021
Q2
2021
Jun 30, 2020
$1.97B
Jul 22, 2021
Q1
2021
Mar 31, 2020
$1.82B
Apr 22, 2021
Q3
2020
Sep 30, 2019
$1.81B
Oct 21, 2020
Q2
2020
Jun 30, 2019
$1.96B
Jul 22, 2020
Q1
2020
Mar 31, 2019
$1.50B
Apr 23, 2020
Q3
2019
Sep 30, 2018
$1.70B
Oct 22, 2019
Q2
2019
Jun 30, 2018
$1.21B
Jul 24, 2019
Q1
2019
Mar 31, 2018
$1.53B
Apr 24, 2019
Q3
2018
Sep 30, 2017
$1.65B
Oct 23, 2018
Q2
2018
Jun 30, 2017
$1.20B
Jul 24, 2018
Q1
2018
Mar 31, 2017
$1.02B
Apr 24, 2018
Q3
2017
Sep 30, 2016
$1.43B
Oct 24, 2017
Q2
2017
Jun 30, 2016
$1.46B
Jul 25, 2017
Q1
2017
Mar 31, 2016
$1.38B
Apr 25, 2017
Q3
2016
Sep 30, 2015
$1.37B
Oct 26, 2016